First Medical: The fund has completed the filing.

The first pharmaceutical announcement, the Shanghai Chuangte Private Equity Investment Fund Partnership Enterprise established by the company has completed the filing procedures on May 13, 2025, with the China Securities Investment Fund Industry Association and obtained the "Private Equity Investment Fund Filing Certificate" with a filing code of SAXM42. The fund manager is Shanghai Shangtou Entrepreneurial Investment Co., Ltd., and the custodian is Huaxia Bank Co., Ltd. The company will continue to monitor the subsequent progress of the fund and fulfill its information disclosure obligations in a timely manner.